Hadley Donald W, Jenkins Jean, Dimond Eileen, Nakahara Kenneth, Grogan Liam, Liewehr David J, Steinberg Seth M, Kirsch Ilan
Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, 10 Center Dr, MSC 1852, Building 10, Room 10C103, Bethesda, MD 20892-1852, USA.
Arch Intern Med. 2003 Mar 10;163(5):573-82. doi: 10.1001/archinte.163.5.573.
Genetic testing to refine cancer risk is available. However, little is known about factors affecting the uptake of testing for the most common hereditary colon cancer, hereditary nonpolyposis colorectal cancer. This study investigated attitudes, intentions, and uptake of genetic testing within newly identified families with hereditary nonpolyposis colorectal cancer.
Cohort study conducted at the National Institutes of Health between April 15, 1996, and November 20, 1999. Data were collected through questionnaires before semistructured education sessions, individual counseling sessions, and the offer of genetic testing.
Of the 111 eligible first-degree relatives, 51% chose to participate in education and individual counseling sessions. Participation was associated with greater numbers of first-degree relatives with cancer; no association was found between participation and personal history of cancer. Before education and individual counseling sessions, 64% of participants had heard little about genetic testing for cancers; however, most (97%) stated intentions to pursue testing. Fifty-one percent identified learning about their children's risks as the most important reason to consider testing. Thirty-nine percent identified the potential effect on their health insurance as the most important reason to not undergo testing. Of the 111 eligible first-degree relatives, 51% chose to undergo genetic testing. Participants' intentions to pursue genetic testing were significantly affected by concerns regarding the ability to handle the emotional aspects of testing and the psychosocial effect on family members.
Genetic counseling and testing offers the potential to focus cancer screening resources in individuals truly at increased risk, thereby reducing mortality and morbidity. Fears of discrimination and concerns about psychological and psychosocial issues may present barriers to the use of current cancer prevention strategies, including genetic counseling and testing.
已有用于精准评估癌症风险的基因检测。然而,对于影响最常见的遗传性结肠癌——遗传性非息肉病性结直肠癌检测接受度的因素,人们知之甚少。本研究调查了新确诊的遗传性非息肉病性结直肠癌家族中对基因检测的态度、意愿及接受情况。
1996年4月15日至1999年11月20日在美国国立卫生研究院开展的队列研究。通过在半结构化教育课程、个体咨询课程及提供基因检测之前进行问卷调查来收集数据。
在111名符合条件的一级亲属中,51%选择参加教育及个体咨询课程。参与情况与患癌的一级亲属数量较多有关;未发现参与情况与个人癌症史之间存在关联。在教育及个体咨询课程之前,64%的参与者对癌症基因检测了解甚少;然而,大多数人(97%)表示有进行检测的意愿。51%的人认为了解子女的风险是考虑检测的最重要原因。39%的人认为对其健康保险的潜在影响是不进行检测的最重要原因。在111名符合条件的一级亲属中,51%选择进行基因检测。参与者进行基因检测的意愿受到对检测情感方面应对能力的担忧以及对家庭成员心理社会影响的担忧的显著影响。
遗传咨询和检测有可能将癌症筛查资源集中于真正风险增加的个体,从而降低死亡率和发病率。对歧视的恐惧以及对心理和心理社会问题的担忧可能会对包括遗传咨询和检测在内的当前癌症预防策略的应用构成障碍。